Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating LIB003 with evolocumab in Homozygous Familial Hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• Evolocumab (evolocumab)
• LIB003

Snippet

Sponsor: LIB Therapeutics LLC | Conditions: Homozygous Familial Hypercholesterolemia | Phase 3 | Status: COMPLETED